New targets for gastrointestinal disease; carbon monoxide as treatment for ARDS; strokes and social networks; aspirin-triggered resolvins
Yu Shrike Zhang, PhD, and team are developing a way to screen drug candidates using three-dimensional structures that look and act the same as human organs and tissues.
Brigham early-career investigators took the stage to share their bold ideas and big projects at the intersection of artificial intelligence and health care.
Arlene Sharpe, MD, PhD, a leader in the field of immunology, discusses advancements in cancer immunotherapy, her path to the Brigham and the importance of mentorship and collaboration
After growing up in a city with one of the highest murder rates in the world, Juan Herrera-Escobar, MD, was motivated to become a trauma researcher.
Brigham investigators are using artificial intelligence to determine how to prevent patients from getting sick from the Clostridioides difficile bacterium
Cooper appointed Kessler Director; Laskowski named executive medical director; Kenney to depart
This month we are asking those running on the Brigham’s 2019 Stepping Strong Marathon Team: Why do you run?
Bite-sized news for busy clinicians and researchers